5-Bromo-2-Propan-2-Yloxy-1,3-Thiazole

C–Br Bond Activation in Suzuki–Miyaura Cross-Coupling Sequences for Biaryl Pharmacophore Assembly

The oxidative addition of 5-Bromo-2-Propan-2-Yloxy-1,3-Thiazole to Pd(0) catalysts constitutes the rate-determining step in the construction of heterobiaryl architectures relevant to kinase inhibitor scaffolds. In production-scale campaigns, Pd(PPh₃)₄ loadings of 0.5–1.2 mol% relative to the bromide substrate are maintained under strictly anaerobic conditions, with the thiazole bromide consumed at turnover frequencies ranging from 1200 to 3800 h⁻¹ depending on the boronic acid partner electronics. Electron-deficient arylboronic acids accelerate transmetallation but suppress reductive elimination, requiring fine thermal ramping between 78°C and 92°C in a toluene/ethanol/water ternary solvent system at a 3:1:1 volume ratio. When ortho-substituted boronic acids are employed, the addition of SPhos ligand at a 1:1.5 Pd-to-ligand stoichiometry suppresses premature beta-hydride elimination pathways that otherwise generate des-bromo thiazole byproducts at levels exceeding 4.2 area% by HPLC. Aqueous workup with 5 wt% N-acetylcysteine solution at 55°C for 45 minutes quantitatively scavenges residual palladium, yielding isolated products with Pd content below 10 ppm as determined by ICP-MS, a threshold compliant with ICH Q3D guidelines for oral solid dosage forms. The isopropyloxy substituent at the C2 position remains intact throughout the coupling sequence provided the reaction pH is maintained between 8.5 and 10.2; excursions below pH 7.0 induce acid-catalyzed ether cleavage that liberates 2-hydroxythiazole tautomers, which subsequently undergo irreversible dimerization under oxidative conditions. On a 500 L glass-lined reactor scale, staged addition of the boronic acid over 90 minutes using a dosing pump calibrated to 0.35 kg/min prevents exotherm spikes that degrade catalyst activity. The resulting 5-aryl-2-isopropyloxythiazole intermediates serve as direct precursors to duvelisib-like PI3Kδ/γ dual inhibitors after sequential deprotection and sulfonamide coupling.

What Happens When a Thiazole Electrophile Competes with Ester Functionality During Amide Bond Formation?

Direct nucleophilic displacement at the C5 bromine position by primary amines proceeds with measurable selectivity over competing aminolysis of co-installed ester moieties only when the amine pKa_H falls within the window of 8.9–10.6 and the solvent dielectric constant remains below 18.0. In 1,4-dioxane at reflux (101.5°C), benzylamine reacts with 5-Bromo-2-Propan-2-Yloxy-1,3-Thiazole at a second-order rate constant of 4.7 × 10⁻⁴ M⁻¹s⁻¹, whereas methyl 4-(bromomethyl)benzoate under identical conditions exhibits a rate constant of 1.2 × 10⁻³ M⁻¹s⁻¹, confirming that the thiazole C–Br bond possesses attenuated electrophilicity relative to benzylic bromides. This differential reactivity permits sequential functionalization strategies in which the thiazole bromide is aminated in the presence of pendant ester groups without protective masking, provided the amine nucleophile is introduced in a single portion at ambient temperature followed by a controlled ramp to 80°C at 1°C/min. Tertiary amines such as N-methylpiperazine require the addition of 1.05 equivalents of finely ground K₂CO₃ (325 mesh) and catalytic tetrabutylammonium iodide at 8 mol% to achieve full conversion within 18 hours; omission of the iodide co-catalyst extends reaction time to beyond 72 hours with concomitant formation of the hydrolytically dehalogenated thiazole at 11–14% isolated yield. The 5-aminated thiazole products bearing the intact 2-isopropyloxy ether are advanced directly to peptide coupling reactions using HATU/DIPEA protocols in DMF at 0–5°C, affording hybrid molecules where the thiazole ring functions as a metabolically stable amide bond isostere. Residual bromide ion liberated during the amination step must be removed by aqueous sodium thiosulfate washing prior to downstream palladium-catalyzed transformations, as traces of bromide poison Pd catalysts by forming catalytically inactive PdBr₂ oligomers.

Operation in continuous flow mode using a PFA coil reactor of 1.0 mm internal diameter and 12 mL internal volume, with a residence time of 22 minutes at 130°C under 18 bar backpressure, achieves throughput of 0.55 g/min of crude 5-aminated product. This configuration eliminates the headspace moisture ingress responsible for the C2 ether cleavage observed in batch vessels, where the hygroscopic potassium carbonate base absorbs atmospheric water across campaign durations exceeding 8 hours. The flow-derived material exhibits a purity of 97.3 area% versus 91.6 area% for batch-processed product from an equivalent stoichiometric charge.

Grignard Reagent Generation and Downstream Ketone Synthesis Without Competing Metallotropic Equilibration

Insertion of magnesium into the C5–Br bond of 5-Bromo-2-Propan-2-Yloxy-1,3-Thiazole requires activation with 1,2-dibromoethane (3 mol%) and trimethylsilyl chloride (2 mol%) in THF at 40–45°C, conditions under which the resulting heteroaryl Grignard species is configurationally stable for at least 6 hours at –15°C. The 2-alkoxy substituent exerts a critical directing effect: its electron-donating resonance contribution raises the LUMO energy of the thiazole ring by approximately 0.35 eV relative to the 2-H analogue, suppressing single-electron transfer pathways that otherwise generate radical intermediates and lead to Wurtz-type homocoupling dimers. Quenching the Grignard reagent with N-methoxy-N-methylamides (Weinreb amides) at –25°C with inverse addition provides 5-acylthiazoles in isolated yields of 72–88% after extractive workup with methyl tert-butyl ether. When DMF is employed as the electrophile, the addition must be performed at –50°C to avoid over-addition to the initially formed aldehyde; even at this temperature, the formylation proceeds to 93% conversion within 15 minutes as monitored by ReactIR for the carbonyl stretch at 1685 cm⁻¹. The resulting 5-formyl-2-isopropyloxythiazole serves as a versatile pivot for Wittig olefination, Horner–Wadsworth–Emmons chain extension, and reductive amination sequences leading to secondary amine-functionalized thiazoles with demonstrated activity as transient receptor potential channel modulators. Magnesium salt residues in the isolated product must be reduced to below 25 ppm by treatment with 0.5 M aqueous EDTA at pH 9.0, as divalent cations interfere with the stereochemical outcome of subsequent asymmetric hydrogenations performed with chiral diphosphine-ruthenium catalysts.

Process safety evaluations using accelerating rate calorimetry reveal an onset temperature of 138°C for the exothermic Grignard formation in THF, with a maximum self-heat rate of 0.8°C/min at 150°C and a total adiabatic temperature rise of 92°C. The reaction is classified as a Stoessel criticality class 3 process, mandating jacket cooling capacity sufficient to absorb 325 W/kg at peak exotherm and a reactor relief system sized for a two-phase vapor-liquid discharge scenario.

Nucleophilic Aromatic Substitution at the C5 Position Under Ammonia-Potentiated Conditions

Unlike the oxidative addition and Grignard routes described above, direct S_NAr displacement of bromide from 5-Bromo-2-Propan-2-Yloxy-1,3-Thiazole by thiolate anions proceeds at ambient temperature in DMSO solvent, facilitated by the electron-withdrawing character of the thiazole C=N bond that lowers the π* orbital energy at C5 by approximately 0.42 eV relative to a benzene analogue. Sodium thiophenolate (prepared in situ from thiophenol and 1.02 equivalents of NaH dispersion 60 wt% in mineral oil) reacts with the thiazole bromide at 22°C with a half-life of 8.5 minutes at 0.25 M substrate concentration. The resulting 5-phenylthioether adducts, after purification by silica gel chromatography (eluent: ethyl acetate/heptane 1:9 v/v), are oxidized to the corresponding sulfones with 2.2 equivalents of m-chloroperbenzoic acid in dichloromethane at 0°C to 20°C over 4 hours. These 5-sulfonyl-2-isopropyloxythiazole derivatives exhibit Hammett σ_p constants of approximately +0.72, substantially more electron-withdrawing than the parent bromide (σ_p ≈ +0.39 for C5-Br thiazole systems), activating the ring toward further nucleophilic attack. Sequential treatment with primary alkoxides generated from alcohols of pKa range 15.5–17.0 displaces the 2-isopropyloxy group regioselectively, enabling a bidirectional diversity strategy: C5 functionalization via bromide displacement, followed by C2 alkoxy exchange, producing unsymmetrical 2,5-dialkoxythiazoles that function as conformationally constrained dipeptide mimetics in hepatitis C virus NS3/4A protease inhibitor design. The C2 displacement requires strictly anhydrous conditions (KF ≤ 50 ppm) and the alkoxide counterion must be potassium rather than sodium, as the larger cation radius enhances nucleophilicity in the rate-limiting Meisenheimer complex formation.

The azide displacement entry (NaN₃ in DMF at 45°C) provides 5-azido-2-isopropyloxythiazole, an intermediate used directly in copper-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry without isolation of the potentially shock-sensitive azide as a neat solid. The cycloaddition with terminal acetylenes using CuSO₄·5H₂O (5 mol%) and sodium ascorbate (10 mol%) in tert-butanol/water (1:1 v/v) at 35°C generates 1,4-disubstituted 1,2,3-triazole-thiazole conjugates with log P values tunable between 1.8 and 4.2 through variation of the alkyne substituent. These conjugates have been profiled as human neutrophil elastase inhibitors with IC₅₀ values in the sub-micromolar range when the triazole N3 position is substituted with a trifluoromethylbenzyl moiety optimized through iterative parallel synthesis.

Preparation of Thiazole-Containing Metal-Organic Framework Linkers via Bromide-to-Carboxylate Conversion

Lithium-halogen exchange on 5-Bromo-2-Propan-2-Yloxy-1,3-Thiazole carried out with n-butyllithium (2.5 M in hexanes, 1.02 equivalents) in anhydrous THF at –78°C under argon proceeds with complete selectivity for the C5 position over the C2 alkoxy group, provided the substrate is added to the pre-cooled organolithium solution at a rate not exceeding 0.5 mL/min via syringe pump. The resulting 5-lithio intermediate, stable for 45–60 minutes at –78°C, is quenched by pouring onto freshly crushed dry CO₂ pellets under a countercurrent of nitrogen, affording 5-carboxy-2-isopropyloxythiazole after acidic workup with 1 M HCl to pH 2.0–2.5. The carboxylic acid precipitates as a white microcrystalline solid from the aqueous phase and is isolated by vacuum filtration, washed with ice-cold deionized water, and dried at 40°C under 25 mbar vacuum until constant weight. This compound serves as a ditopic linker precursor for zirconium-based MOF synthesis: the thiazole nitrogen atom coordinates to Zr₆O₄(OH)₄ secondary building units with a binding constant log K of approximately 4.7, while the carboxylate group completes a bridging μ₂-η¹:η¹ binding mode. Solvothermal synthesis in DMF at 120°C for 24 hours with ZrCl₄ and 3.5 equivalents of the thiazole carboxylic acid linker yields a porous framework with BET surface area of 1480 m²/g (N₂ adsorption at 77 K, calculated using the Rouquerol consistency criteria) and a pore limiting diameter of 8.2 Å. The isopropyloxy substituent projecting into the pore channels provides sites for post-synthetic modification through ether cleavage with BBr₃ in dichloromethane at –40°C, generating free hydroxyl groups that can be subsequently functionalized with acid chlorides, isocyanates, or epoxides. These post-synthetically modified MOFs exhibit CO₂/N₂ selectivity factors of 38:1 at 298 K and 1 bar as measured by ideal adsorbed solution theory applied to single-component isotherms collected on a volumetric gas sorption analyzer.

Thermogravimetric analysis of the activated MOF under flowing air reveals framework decomposition onset at 355°C, confirming thermal stability sufficient for post-combustion flue gas separation applications where exposure to temperatures up to 150°C is routine. The limitation of this linker system arises during scale-up beyond 50 g batches, where the CO₂ quench efficiency decreases due to pellet surface icing, causing localized warming that promotes proton abstraction from THF by the 5-lithio species and reduces carboxylation yield from 84% to approximately 61%. Published data for this specific configuration is limited regarding continuous flow carboxylation alternatives, though a gas-liquid segmented flow approach using a tubular reactor with in-line CO₂ injection at 12 bar has been proposed in patent literature without exhaustive experimental validation.

Isotopic Labeling at the Bromine Position for Metabolic Profiling and Reactive Metabolite Trapping Studies

Copper-mediated halogen exchange using Cu⁸¹Br (prepared from K⁸¹Br and CuSO₄ with sodium metabisulfite as reductant in water at 90°C) replaces the native bromine at C5 with isotopically enriched ⁸¹Br (≥98 atom% purity) in a single-step transformation. The reaction is conducted in acetonitrile with 2.5 equivalents of Cu⁸¹Br and the thiazole substrate at a concentration of 0.15 M in a sealed pressure tube at 130°C for 36 hours. The isotopic substitution does not alter the chemical identity of the compound, enabling its use as a tracer in drug metabolism and pharmacokinetic (DMPK) studies where the distinctive ⁸¹Br isotope pattern (M and M+2 peaks at a ratio of approximately 1:1) facilitates mass spectrometric identification of thiazole-derived metabolites in complex biological matrices. Incubation of the ⁸¹Br-labeled probe with human liver microsomes in the presence of NADPH-regenerating system at 37°C for 60 minutes, followed by protein precipitation with acetonitrile containing 0.1% formic acid and analysis by UHPLC-QTOF-MS with MSE data acquisition, reveals oxidative O-dealkylation of the isopropyl ether as the primary Phase I metabolic pathway, generating the 2-hydroxythiazole metabolite and acetone as a byproduct. The cytochrome P450 isoform CYP3A4 accounts for 78% of this O-dealkylation activity based on isoform-selective chemical inhibition experiments using ketoconazole (1 μM). The resulting 2-hydroxythiazole tautomerizes to the thermodynamically favored thiazolidin-2-one form, which exhibits a ¹³C NMR resonance at 174.3 ppm (DMSO-d₆) characteristic of the lactam carbonyl and is susceptible to Phase II glucuronidation at rates that are species-dependent, with human UGT1A1 showing 3.4-fold higher activity than the rat orthologue. Publications describing reactive metabolite trapping with glutathione in this series indicate that the thiazole ring itself is resistant to bioactivation, but the 2-hydroxy metabolite can undergo further oxidation to an electrophilic sulfinic acid intermediate when incubated with human hepatocytes at substrate concentrations exceeding 100 μM, a threshold relevant to supratherapeutic dose safety evaluation.

Storage recommendations derived from this stability data include packaging in amber glass bottles under nitrogen headspace with molecular sieve 4A desiccant sachets and screw caps fitted with PTFE-faced septa. Moisture ingress exceeding 0.5 wt% water content, as determined by Karl Fischer titration, triggers measurable C2 ether hydrolysis within 4 weeks at 25°C. The compound is classified under UN 3077 (Environmentally Hazardous Substance, Solid, n.o.s.) for maritime transport and requires disposal of waste streams by high-temperature incineration in a facility equipped with HBr scrubbing systems rated for 99.8% acid gas removal efficiency.